rxstat › Shortages › Rubella Virus Live Attenuated Mumps Measles Varicella
Rubella Virus Live Attenuated Mumps Measles Varicella (Proquad) shortage status
No current shortage
A vaccine used to protect against measles, mumps, rubella, and chickenpox.
Reports by product
What's happening
There are no active shortage reports for Rubella Virus Live Attenuated Mumps Measles Varicella. Health Canada has 6 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Rubella Virus Live Attenuated Mumps Measles Varicella is classified under “VIRAL VACCINES” (ATC J07BD).
Recent changes
- No changes recorded yet.
Common questions
What is Rubella Virus Live Attenuated Mumps Measles Varicella used for?
A vaccine used to protect against measles, mumps, rubella, and chickenpox.
When will Rubella Virus Live Attenuated Mumps Measles Varicella be back in stock in Canada?
Rubella Virus Live Attenuated Mumps Measles Varicella has no active shortage; supply is normal per Health Canada reports.
Why is Rubella Virus Live Attenuated Mumps Measles Varicella in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (viral vaccines)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.